The Effects of Soluble A&bgr; Oligomers on Neurodegeneration in Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|15|2506-2519

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.15, 2014-05, pp. : 2506-2519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signaling Mechanisms Underlying A&bgr; Toxicity: Potential Therapeutic Targets for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 355-361

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Modulation of A&bgr;42 Production in Alzheimer's Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4337-4355

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Amyloid &bgr;-Protein and Its Associated Molecules in the Pathogenesis of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1075-1080

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of &bgr;-Amyloid Protein in Synaptic Function: Implications for Alzheimer's Disease Therapy

By  

Current Neuropharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 149-163

Bentham Science Publishers

Access to resources Recommend Favorite

The Amyloid &bgr;-Protein Precursor and Alzheimer's Disease. Therapeutic Approaches

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-12 ,pp. : 271-283

Bentham Science Publishers

Access to resources Recommend Favorite